Michael Yurkowsky
Directeur Général chez INNOVEREN SCIENTIFIC INC.
Fortune : 306 $ au 31/03/2024
Postes actifs de Michael Yurkowsky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INNOVEREN SCIENTIFIC INC. | Directeur/Membre du Conseil | 08/01/2019 | - |
| Directeur Général | 06/12/2021 | - | |
| Independent Dir/Board Member | - | - | |
| YP Holdings LLC (Florida) | Corporate Officer/Principal | - | - |
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Directeur Général | - | - |
| Fondateur | - | - | |
| President | - | - | |
| Immuni-T, Inc. | Directeur Général | - | - |
Jantibody LLC
 Jantibody LLC Pharmaceuticals: MajorHealth Technology Part of Innoveren Scientific, Inc., Jantibody LLC is a company that provides cancer treatment drugs. The company is based in St. Augustine, FL. Jantibody was acquired by Innoveren Scientific, Inc. on September 08, 2022 for $0.23 million. | President | - | - |
Historique de carrière de Michael Yurkowsky
Anciens postes connus de Michael Yurkowsky
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 21/05/2019 | 22/09/2022 |
Wachovia Securities LLC
 Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Corporate Officer/Principal | 01/08/2003 | 01/08/2003 |
| Trenchant Asset Management Ltd. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
Sectorielle
| Health Technology | 5 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Health Technology |
| INNOVEREN SCIENTIFIC INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Wachovia Securities LLC
Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Finance |
| Trenchant Asset Management Ltd. | |
| YP Holdings LLC (Florida) | |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
| Immuni-T, Inc. | |
Jantibody LLC
Jantibody LLC Pharmaceuticals: MajorHealth Technology Part of Innoveren Scientific, Inc., Jantibody LLC is a company that provides cancer treatment drugs. The company is based in St. Augustine, FL. Jantibody was acquired by Innoveren Scientific, Inc. on September 08, 2022 for $0.23 million. | Health Technology |
- Bourse
- Insiders
- Michael Yurkowsky
- Expérience